There’s no denying that patient hubs are increasingly becoming a vital platform for dialogue between drug companies and patients seeking specific therapies. However, this communication mode has flaws; and improvement is needed to provide direct communication channels between patients and manufacturers. As technology continues to evolve, it’s expected that the adoption of innovative solutions will be a significant trend in the coming year, particularly to address the specific needs of patients.

Recently, Suzette DiMascio, executive vice president of FFF Enterprises/InCircle Review and advisory board member for Zensight, was quoted in an article by Pharmaceutical Executive [] sharing her thoughts on how technology will play a big role in advancing pharma approaches in patient support.

“Manufacturers spend a lot of time mapping the ideal patient experience and always try to create their program to complement that patient journey,” says DiMascio. “Many times, I think they [companies] get swayed by the vendor that gives the best presentation, and choosing the wrong partner can impact particular patient disease journey that they’re trying to assist.”

Click Here for the Full Article

Continue Reading